California State Teachers Retirement System (CalSTRS)’s Aardvark Therapeutics AARD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.6K Sell
689
-95
-12% -$985 ﹤0.01% 2900
2025
Q4
$10.3K Buy
784
+429
+121% +$5.35K ﹤0.01% 2772
2025
Q3
$4.72K Buy
355
+1
+0.3% +$11 ﹤0.01% 2987
2025
Q2
$4.79K Buy
+354
New +$3.65K ﹤0.01% 2908

Other funds holding AARD

California State Teachers Retirement System (CalSTRS)'s AARD Position: Q1 2026 in Review

California State Teachers Retirement System (CalSTRS) reduced its Aardvark Therapeutics (AARD) stake by 12% in Q1 2026, selling an estimated $985 and leaving 689 shares worth $2.6K. The position accounts for ﹤0.01% of the portfolio, ranked #2900.

California State Teachers Retirement System (CalSTRS) first reported a position in AARD in Q2 2025 and has held it in 4 quarters since. The position peaked at $10.3K in Q4 2025. 79 funds tracked by Wall St. Rank hold AARD as of Q1 2026.

  • California State Teachers Retirement System (CalSTRS) held 689 shares of Aardvark Therapeutics worth $2.6K as of Q1 2026.
  • California State Teachers Retirement System (CalSTRS) sold 95 Aardvark Therapeutics shares in Q1 2026, an estimated $985.
  • Aardvark Therapeutics made up ﹤0.01% of California State Teachers Retirement System (CalSTRS)'s portfolio in Q1 2026, its #2900 holding.
  • California State Teachers Retirement System (CalSTRS) first reported a position in Aardvark Therapeutics in Q2 2025 and has held it in 4 quarters since.
  • California State Teachers Retirement System (CalSTRS)'s Aardvark Therapeutics position peaked at $10.3K in Q4 2025.
  • 79 funds tracked by Wall St. Rank held Aardvark Therapeutics as of Q1 2026.

Based on California State Teachers Retirement System (CalSTRS)'s 13F filing for Q1 2026, filed 18 May 2026.